Post by Pascal BOUQUET

Digital Health Transformation and Technology Leader | Health & Life Science | Tech Platforms | Software Engineering

I'm pleased to share Week 25 of the Clinical Data & AI Brief. The dominant signal this week: the pharma AI race has entered its data hoarding phase — Merck's $510M Protillion deal, Lilly's TuneLab expansion, and the Novo Nordisk 1.3TB breach (now pivoting to dark-web private sale) all converge on the same question: who controls the proprietary curated data that will train tomorrow's clinical AI? The answer is being decided right now. Credit: HealthtechPartners 42 For info: Varun Debbeti, Bill Illis

Post content